PL106083B1 - Sposob wytwarzania zasadowo podstawionych pochodnych ksantyny - Google Patents

Sposob wytwarzania zasadowo podstawionych pochodnych ksantyny

Info

Publication number
PL106083B1
PL106083B1 PL1977197407A PL19740777A PL106083B1 PL 106083 B1 PL106083 B1 PL 106083B1 PL 1977197407 A PL1977197407 A PL 1977197407A PL 19740777 A PL19740777 A PL 19740777A PL 106083 B1 PL106083 B1 PL 106083B1
Authority
PL
Poland
Prior art keywords
substitute
making basically
xanthin derivatives
xanthin
derivatives
Prior art date
Application number
PL1977197407A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL106083B1 publication Critical patent/PL106083B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
PL1977197407A 1976-04-15 1977-04-14 Sposob wytwarzania zasadowo podstawionych pochodnych ksantyny PL106083B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15547/76A GB1527543A (en) 1976-04-15 1976-04-15 Basically substituted xanthine derivatives

Publications (1)

Publication Number Publication Date
PL106083B1 true PL106083B1 (pl) 1979-11-30

Family

ID=10061083

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977197407A PL106083B1 (pl) 1976-04-15 1977-04-14 Sposob wytwarzania zasadowo podstawionych pochodnych ksantyny

Country Status (28)

Country Link
US (1) US4144340A (pl)
JP (1) JPS52128396A (pl)
AR (1) AR217426A1 (pl)
AT (1) AT350070B (pl)
AU (1) AU511983B2 (pl)
BE (1) BE853571A (pl)
CA (1) CA1078379A (pl)
CH (1) CH631454A5 (pl)
CS (1) CS196357B2 (pl)
DE (1) DE2716210A1 (pl)
DK (1) DK141051B (pl)
ES (2) ES457784A1 (pl)
FI (1) FI61900C (pl)
FR (1) FR2361395A1 (pl)
GB (1) GB1527543A (pl)
GR (1) GR63643B (pl)
IN (1) IN145872B (pl)
IT (1) IT1143568B (pl)
MX (1) MX5064E (pl)
NL (1) NL7704087A (pl)
NO (1) NO148291C (pl)
NZ (1) NZ183859A (pl)
PL (1) PL106083B1 (pl)
PT (1) PT66442B (pl)
RO (1) RO72835A (pl)
SE (1) SE431335B (pl)
SU (1) SU668604A3 (pl)
ZA (1) ZA772294B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935062A1 (de) * 1978-09-06 1980-03-20 Degussa Substituierte aminoalkylguanidine, deren herstellung und arzneimittel
EP0022321A1 (en) * 1979-07-10 1981-01-14 Beecham Group Plc Benzene derivatives, their preparation and use in pharmaceutical compositions
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
CH655658B (pl) * 1980-09-18 1986-05-15
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4406903A (en) * 1981-01-21 1983-09-27 John Wyeth And Brother Limited Xanthine derivatives useful as antidepressives
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT308139B (de) * 1970-07-27 1973-06-25 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen, ihren Isomeren und Säureadditionssalzen
AT311995B (de) * 1971-09-06 1973-12-10 Degussa Verfahren zur Herstellung von neuen basisch substituierten Alkyltheophyllinen
AT313916B (de) * 1971-10-28 1974-03-11 Degussa Verfahren zur Herstellung von neuen basisch substituierten Theophyllinen und deren Säureadditionssalzen
DE2308826C3 (de) * 1973-02-22 1980-03-27 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel

Also Published As

Publication number Publication date
AU511983B2 (en) 1980-09-18
DK141051B (da) 1979-12-31
GR63643B (en) 1979-11-28
AR217426A1 (es) 1980-03-31
NO771301L (no) 1977-10-18
RO72835B (ro) 1983-07-30
FI61900B (fi) 1982-06-30
NO148291C (no) 1983-09-14
DK166677A (pl) 1977-10-16
MX5064E (es) 1983-03-09
ES457783A1 (es) 1978-03-01
IT1143568B (it) 1986-10-22
DE2716210A1 (de) 1977-11-03
NL7704087A (nl) 1977-10-18
CS196357B2 (en) 1980-03-31
RO72835A (ro) 1983-08-03
NO148291B (no) 1983-06-06
BE853571A (nl) 1977-10-14
SE431335B (sv) 1984-01-30
JPS52128396A (en) 1977-10-27
ZA772294B (en) 1978-03-29
ATA262677A (de) 1978-10-15
ES457784A1 (es) 1978-03-01
PT66442A (pt) 1977-05-01
SE7704319L (sv) 1977-11-28
FI61900C (fi) 1982-10-11
SU668604A3 (ru) 1979-06-15
GB1527543A (en) 1978-10-04
DK141051C (pl) 1980-06-16
FI771187A (pl) 1977-10-16
PT66442B (pt) 1978-09-22
US4144340A (en) 1979-03-13
FR2361395B1 (pl) 1981-02-13
FR2361395A1 (fr) 1978-03-10
CH631454A5 (de) 1982-08-13
CA1078379A (en) 1980-05-27
NZ183859A (en) 1979-03-28
IN145872B (pl) 1979-01-06
AU2425677A (en) 1978-10-19
AT350070B (de) 1979-05-10

Similar Documents

Publication Publication Date Title
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL205498A1 (pl) Sposob wytwarzania pochodnych morfiny
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL106083B1 (pl) Sposob wytwarzania zasadowo podstawionych pochodnych ksantyny
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL196356A1 (pl) Sposob wytwarzania pochodnych puryny
PL215005A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL197646A1 (pl) Sposob wytwarzania pochodnych 1-karbamylouracylu
PL196061A1 (pl) Sposob wytwarzania nowych pochodnych indolizyny